Viral Gastroenteritis Global Market Report 2023: A $7.68 Billion Market by 2027 - Product Innovation and FDA Approvals Fuel Growth to 2032
October 10, 2023 07:18 ET
|
Research and Markets
Dublin, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The "Viral Gastroenteritis Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global viral gastroenteritis market is...
Novozymes OneHealth and Juneyao Health announced a strategic partnership at 14th ACN
September 21, 2023 01:23 ET
|
Novozymes OneHealth
Chengdu, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The 14th Asian Congress of Nutrition(ACN), held in Chengdu, China from September 14th to 17th, 2023 brought together experts and enthusiasts in the field...
Constipation Treatment Market to Reach $10.1 Billion by 2032, exhibiting a CAGR of 5.6% from 2023 to 2032: Allied Market Research
September 07, 2023 09:00 ET
|
Allied Market Research
New Castle, Delaware, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Constipation treatment Market by Product Type (Mu-Opioid Receptor Antagonists, Laxative,...
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
August 28, 2023 08:19 ET
|
Biomerica, Inc.
Kenny has proven track record of driving growth at companies within the healthcare space and holds significant management and public company board experience, most recently as CEO of Meridian...
Biomerica Reports Fiscal 2023 Year End Results
August 25, 2023 17:00 ET
|
Biomerica, Inc.
Revenues excluding Covid test sales increased 15% for fiscal 2023 vs fiscal 2022 Successfully completed inFoods® IBS pilot program with one of the largest Gastrointestinal physician groups in the US ...
Biomerica Receives Notice of Patent Allowance in China for a Potential Innovative Technology That Includes an Artificial Intelligence (AI) Claim for Predicting Foods That Contain Ingredients That Cause Adverse Reactions in Patients
June 21, 2023 08:19 ET
|
Biomerica, Inc.
Patent Claims Describe a Novel System to Predict and Help Prevent Adverse Food Reactions Using Personal Medical DataThe Patent further describes Algorithms to help Determine Safety Levels of Food...
Global Gastrointestinal Partnering Analysis Report 2023: Deal Trends, Players and Financials for Over 480 Deals Signed Since 2016 by the World's Leading Life Science Companies
May 31, 2023 03:13 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Gastrointestinal Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.Global...
Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).
April 17, 2023 07:47 ET
|
Biomerica, Inc.
Gastro Health is a leading gastroenterology group with over 380 GI physicians in the United StatesClinical study results show patients who eliminated foods as determined by the inFoods® IBS test...
Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed
March 08, 2023 08:19 ET
|
Biomerica, Inc.
InFoods® IBS LDT validation testing at the CLIA Lab is completed and the product is now being offered commerciallyClinical trial data shows InFoods® IBS treatment diet significantly improved several...
Irritable Bowel Syndrome Pipeline Booms as 24+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
January 18, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Irritable Bowel Syndrome Pipeline Booms as 24+ Therapies Likely to Enter in the Treatment Domain | DelveInsight Irritable bowel syndrome (IBS) is a...